IGLC2 and arrhythmogenic right ventricular cardiomyopathy: In the results of KEGG pathway enrichment analysis, IGLC2 may influence the progression of TNBC via the PI3K-Akt signaling pathway, MAPK signaling pathway, ECM–receptor interaction, HCM, DCM, and ARVC.